https://ir.bullfrogai.com/ https://ir.bullfrogai.com/news-events/press-releases https://ir.bullfrogai.com/news-events/in-the-news https://ir.bullfrogai.com/news-events/ir-calendar https://ir.bullfrogai.com/news-events/presentations https://ir.bullfrogai.com/news-events/email-alerts https://ir.bullfrogai.com/company-information https://ir.bullfrogai.com/company-information/contacts https://ir.bullfrogai.com/company-information/faq https://ir.bullfrogai.com/financial-information/financial-results https://ir.bullfrogai.com/stock-data/quote-chart https://ir.bullfrogai.com/stock-data/historical-data https://ir.bullfrogai.com/sec-filings/all-sec-filings https://ir.bullfrogai.com/sec-filings/annual-reports https://ir.bullfrogai.com/sec-filings/quarterly-reports https://ir.bullfrogai.com/sec-filings/section-16-filings https://ir.bullfrogai.com/corporate-governance https://ir.bullfrogai.com/corporate-governance/board-of-directors https://ir.bullfrogai.com/corporate-governance/board-committees https://ir.bullfrogai.com/corporate-governance/governance-documents https://ir.bullfrogai.com/news-events/press-releases/detail/82/bullfrog-ai-announces-commercial-agreement-with-top-5-global-pharmaceutical-company-to-identify-and-prioritize-therapeutic-target-in-major-depressive-disorder https://ir.bullfrogai.com/news-events/press-releases/detail/81/bullfrog-ai-unveils-bfarenas-scenario-based-decision-engine https://ir.bullfrogai.com/news-events/press-releases/detail/80/bullfrog-to-host-webinar-on-new-precision-ai-capability https://ir.bullfrogai.com/news-events/press-releases/detail/79/bullfrog-ai-to-unveil-new-precision-ai-capability https://ir.bullfrogai.com/news-events/press-releases/detail/78/bullfrog-ai-on-data-harmonization-the-hidden-prerequisitefor-reliable-aiml-in-life-sciences https://ir.bullfrogai.com/news-events/press-releases/detail/77/bullfrog-ai-driven-precision-oncology-analytics-identifies-3x-increase-in-overall-survivability-in-patient-subgroups-through-key-biomarkers-in-pancreatic-cancer https://ir.bullfrogai.com/news-events/press-releases/detail/76/bullfrog-ai-publishes-annual-letter-to-shareholders https://ir.bullfrogai.com/news-events/press-releases/detail/75/bullfrog-ai-publishes-whitepaper-on-ai-in-bioinformatics-turning-complex-data-into-actionable-insights https://ir.bullfrogai.com/news-events/press-releases/detail/74/bullfrog-ai-to-present-bfprep-at-the-ai-drug-discovery-development-summit-2025 https://ir.bullfrogai.com/news-events/press-releases/detail/73/bullfrog-ai-announces-abstract-accepted-for-presentation-at-2026-asco-gastrointestinal-cancers-symposium https://ir.bullfrogai.com/news-events/press-releases/detail/72/join-bullfrog-ais-exclusive-live-investor-webinar-and-qa-session-on-october-30 https://ir.bullfrogai.com/news-events/press-releases/detail/71/bullfrog-ai-expands-sales-and-marketing-team-to-accelerate-commercial-adoption-of-clinical-trial-optimization-solutions-and-bfprep-module https://ir.bullfrogai.com/news-events/press-releases/detail/70/bullfrog-ai-and-sygnature-discovery-announce-official-sales-launch-of-bullfrog-data-networks-to-global-biopharma-clients https://ir.bullfrogai.com/news-events/press-releases/detail/69/bullfrog-ai-to-showcase-ai-powered-clinical-data-solutions-in-xtalks-webinar https://ir.bullfrogai.com/news-events/press-releases/detail/68/bullfrog-ais-bfprep-and-bfleap-platforms-deliver-real-world-impact-in-eleison-pharmaceuticals-collaboration https://ir.bullfrogai.com/news-events/press-releases/detail/67/bullfrog-ai-to-present-at-btig-annual-virtual-biotechnology-conference https://ir.bullfrogai.com/news-events/press-releases/detail/66/rethinking-rd-bullfrog-ai-white-paper-outlines-new-blueprint-for-smarter-drug-development https://ir.bullfrogai.com/news-events/press-releases/detail/65/join-bullfrog-ais-exclusive-live-investor-webinar-and-qa-session-on-july-23 https://ir.bullfrogai.com/news-events/press-releases/detail/64/bullfrog-ai-launches-bfprep-a-new-ai-powered-data-preparation-module-in-its-bullfrog-data-networks-solutions-library https://ir.bullfrogai.com/news-events/press-releases/detail/63/bullfrog-ai-unveils-bullfrog-data-networks-solutions-library-expanding-scalable-ai-powered-biomedical-insight-platform-to-large-enterprises https://ir.bullfrogai.com/news-events/press-releases/detail/62/bullfrog-ais-dr-juan-felipe-beltrn-to-highlight-advanced-ai-strategies-in-bioinformatics-at-xtalks-webinar https://ir.bullfrogai.com/news-events/press-releases/detail/61/bullfrog-ai-announces-strategic-collaboration-with-sygnature-discovery-to-introduce-bullfrog-data-networks-to-global-biopharma-clients https://ir.bullfrogai.com/news-events/press-releases/detail/60/join-bullfrog-ais-exclusive-live-investor-webinar-and-qa-session-on-april-23 https://ir.bullfrogai.com/news-events/press-releases/detail/59/bullfrog-ai-and-eleison-pharmaceuticals-enter-agreement-to-collaborate-to-optimize-pivotal-phase-3-trial https://ir.bullfrogai.com/news-events/press-releases/detail/58/bullfrog-ai-to-present-at-biotech-showcase-and-resi-jpm-during-jp-morgan-week https://ir.bullfrogai.com/news-events/press-releases/detail/57/bullfrog-ai-issues-letter-to-stockholders https://ir.bullfrogai.com/news-events/press-releases/detail/56/bullfrog-ai-announces-appointment-of-chief-financial-officer https://ir.bullfrogai.com/news-events/press-releases/detail/55/bullfrog-ais-vp-artificial-intelligence-to-present-at-googles-cancer-ai-symposium https://ir.bullfrogai.com/news-events/press-releases/detail/54/bullfrog-ai-announces-closing-of-registered-direct-offering-and-concurrent-private-placement-for-aggregate-gross-proceeds-of-3-13-million https://ir.bullfrogai.com/news-events/press-releases/detail/53/bullfrog-ai-announces-pricing-of-registered-direct-offering-and-concurrent-private-placement-for-aggregate-gross-proceeds-of-3-13-million https://ir.bullfrogai.com/news-events/press-releases/detail/52/bullfrog-ai-strengthens-scientific-advisory-board-with-the-addition-of-gsk-veteran-and-industry-pioneer-dr-john-baldoni https://ir.bullfrogai.com/news-events/press-releases/detail/51/bullfrog-ai-announces-publication-of-data-supporting-potential-of-liver-disease-treatment-candidate-bf-114 https://ir.bullfrogai.com/news-events/press-releases/detail/50/bullfrog-ai-to-participate-at-the-h-c-wainwright-26th-annual-global-investment-conference https://ir.bullfrogai.com/news-events/press-releases/detail/49/bullfrog-ai-and-lieber-institute-for-brain-development-reveal-new-insights-into-bipolar-disorder-pathways-and-potential-drug-targets https://ir.bullfrogai.com/news-events/press-releases/detail/48/join-bullfrog-ais-exclusive-live-investor-webinar-and-qa-session-on-june-12 https://ir.bullfrogai.com/news-events/press-releases/detail/47/bullfrog-ai-and-lieber-institute-for-brain-development-collaboration-identifies-novel-drug-targets-for-neuropsychiatric-disorders https://ir.bullfrogai.com/news-events/press-releases/detail/46/bullfrog-ais-cso-tom-chittenden-to-present-at-the-quantum-computing-symposium-at-bio-it-world-conference-expo https://ir.bullfrogai.com/news-events/press-releases/detail/45/bullfrog-ai-announces-availability-of-fireside-chat-recording-featuring-ceos-of-bullfrog-ai-and-the-lieber-institute https://ir.bullfrogai.com/news-events/press-releases/detail/44/bullfrog-ai-appoints-globally-renowned-biomedical-ai-expert-dr-thomas-w-chittenden-as-chief-scientific-officer https://ir.bullfrogai.com/news-events/press-releases/detail/43/bullfrog-ai-announces-underwriters-decision-to-exercise-over-allotment-option-to-purchase-218382-shares-of-the-companys-common-stock https://ir.bullfrogai.com/news-events/press-releases/detail/42/bullfrog-ai-to-discuss-findings-from-its-collaboration-with-lieber-institute-for-brain-development-in-fireside-chat-hosted-by-redchip https://ir.bullfrogai.com/news-events/press-releases/detail/41/bullfrog-ai-announces-closing-of-5-7-million-public-offering https://ir.bullfrogai.com/news-events/press-releases/detail/40/bullfrog-ai-announces-pricing-of-5-7-million-public-offering https://ir.bullfrogai.com/news-events/press-releases/detail/39/bullfrog-ai-strengthens-scientific-advisory-board-with-the-addition-of-dr-gwenn-smith-and-dr-jeremiah-wala https://ir.bullfrogai.com/news-events/press-releases/detail/38/bullfrog-ais-collaboration-with-lieber-institute-for-brain-development-yields-potentially-groundbreaking-biological-stratification-of-brain-expression-data https://ir.bullfrogai.com/news-events/press-releases/detail/37/bullfrog-ai-announces-issuance-of-australian-patent-protecting-novel-prodrugs-of-mebendazole-and-their-use-in-treating-cancer https://ir.bullfrogai.com/news-events/press-releases/detail/36/bullfrog-ai-to-present-at-webull-live-healthcare-webinar-on-january-17 https://ir.bullfrogai.com/news-events/press-releases/detail/35/bullfrog-ai-issues-letter-to-shareholders https://ir.bullfrogai.com/news-events/press-releases/detail/34/bullfrog-ai-launches-preclinical-study-to-investigate-bf-114s-potential-in-battling-obesity https://ir.bullfrogai.com/news-events/press-releases/detail/33/bullfrog-ai-to-present-at-benzinga-all-access-event-on-october-20 https://ir.bullfrogai.com/news-events/press-releases/detail/32/bullfrog-ai-announces-identification-of-novel-potential-drug-targets-for-colorectal-cancer-using-its-ai-driven-bfleap-platform https://ir.bullfrogai.com/news-events/press-releases/detail/31/bullfrog-ai-announces-positive-data-from-preclinical-study-evaluating-novel-prodrug-of-mebendazole-for-treatment-of-glioblastoma https://ir.bullfrogai.com/news-events/press-releases/detail/30/bullfrog-ai-founder-and-ceo-vin-singh-to-present-company-overview-at-biofuture-2023 https://ir.bullfrogai.com/news-events/press-releases/detail/29/bullfrog-ai-announces-launch-of-bullfrog-data-networks-a-data-insights-tool-powered-by-the-bfleap-platform https://ir.bullfrogai.com/news-events/press-releases/detail/28/bullfrog-ai-founder-and-ceo-vin-singh-to-present-company-overview-at-maxim-groups-emerging-growth-in-ai-virtual-tech-conference-series https://ir.bullfrogai.com/news-events/press-releases/detail/27/bullfrog-ai-announces-three-year-global-strategic-partnership-withthe-lieber-institute-for-brain-development https://ir.bullfrogai.com/news-events/press-releases/detail/26/bullfrog-ai-announces-investor-webinar-with-ceo-and-founder-vin-singh-on-thursday-september-14-2023 https://ir.bullfrogai.com/news-events/press-releases/detail/25/bullfrog-ai-technology-licensed-from-johns-hopkins-university-apl-named-finalist-in-rd-100-awards https://ir.bullfrogai.com/news-events/press-releases/detail/24/bullfrog-ai-announces-issuance-of-u-s-patent-protecting-novel-prodrugs-of-mebendazole-and-their-use-in-treating-cancer https://ir.bullfrogai.com/news-events/press-releases/detail/23/bullfrog-ai-announces-appointment-of-enrique-garca-rivera-as-vice-president-of-artificial-intelligence https://ir.bullfrogai.com/news-events/press-releases/detail/22/bullfrog-ai-ceo-vin-singh-to-present-at-the-gujarati-physicians-convention-2023 https://ir.bullfrogai.com/news-events/press-releases/detail/21/bullfrog-ai-continues-to-expand-team-with-appointment-of-new-vp-of-business-development https://ir.bullfrogai.com/news-events/press-releases/detail/20/bullfrog-ai-strengthens-capabilities-of-its-ai-platform-through-expansion-of-licensing-agreement-with-johns-hopkins-applied-physics-laboratory https://ir.bullfrogai.com/news-events/press-releases/detail/19/bullfrog-ai-files-quarterly-report-on-form-10-q https://ir.bullfrogai.com/news-events/press-releases/detail/18/bullfrog-ai-ceo-vin-singh-to-present-at-jmp-securities-life-sciences-conference https://ir.bullfrogai.com/news-events/press-releases/detail/17/bullfrog-ai-ceo-vin-singh-to-participate-in-panel-discussion-at-pharma-partnering-summit https://ir.bullfrogai.com/news-events/press-releases/detail/16/bullfrog-ai-files-2022-annual-report-on-form-10-k https://ir.bullfrogai.com/news-events/press-releases/detail/15/bullfrog-ai-partners-with-the-sage-group-to-explore-jv-opportunities-to-advance-its-oncology-assets https://ir.bullfrogai.com/news-events/press-releases/detail/14/bullfrog-ai-announces-licensing-agreement-with-johns-hopkins-university-for-oncology-asset https://ir.bullfrogai.com/news-events/press-releases/detail/13/bullfrog-ai-ceo-vin-singh-to-participate-in-panel-discussion-at-money-show-in-las-vegas https://ir.bullfrogai.com/news-events/press-releases/detail/12/bullfrog-ai-ceo-vin-singh-discusses-how-ai-is-transforming-drug-development-in-exclusive-interview-airing-on-bloomberg-us-on-the-redchip-money-report https://ir.bullfrogai.com/news-events/press-releases/detail/11/bullfrog-ai-announces-exclusive-worldwide-licensing-agreement-with-johns-hopkins-applied-physics-laboratory-for-patented-ai-technology https://ir.bullfrogai.com/news-events/press-releases/detail/10/bullfrog-ai-now-featured-on-webull-corporate-communications-service-platform https://ir.bullfrogai.com/news-events/press-releases/detail/9/bullfrog-ai-partners-with-j-craig-venter-institute-to-develop-colorectal-cancer-therapeutic https://ir.bullfrogai.com/news-events/press-releases/detail/8/bullfrog-ai-announces-closing-of-8-4-million-initial-public-offering https://ir.bullfrogai.com/news-events/press-releases/detail/7/bullfrog-ai-to-present-at-benzinga-all-access-event-on-friday-february-17 https://ir.bullfrogai.com/news-events/press-releases/detail/6/bullfrog-ai-announces-pricing-of-initial-public-offering https://ir.bullfrogai.com/news-events/press-releases/detail/5/bullfrog-ai-enters-into-licensing-agreement-with-johns-hopkins-university-for-use-of-novel-formulation-of-mebendazole-for-treatment-of-cancer https://ir.bullfrogai.com/privacy-policy https://ir.bullfrogai.com/disclaimer https://ir.bullfrogai.com/sitemap